SAYPHA pozycji w ofercie ALLPARA do użytku profesjonalnego, kupowanych bezpośrednio i z certyfikatem przy każdej wysyłce.
Saypha Lips Lidocaine
Saypha Lips Lidocaine is a viscoelastic implant from Croma-Pharma in Austria, designed for lip augmentation and moderate to severe nasolabial folds. Practitioners must inject it into the mid to deep dermis or submucosa, using the needle or an affixed 25G x 2 inch or 22G x 2 3/4 inch cannula. Its cross-linked hyaluronic acid from Streptococcus equi bacteria, phosphate buffered at pH 6.7 to 7.3, gives 2.3% sodium hyaluronate (23 mg/mL) and lidocaine HCl 0.3%. Each box holds one pre-filled 1.0 mL syringe with two 27G 1/2 inch needles, three patient record labels and an international implant card.
Najważniejsze zalety: Saypha Lips Lidocaine
- Indicated for lip augmentation and for correcting moderate to severe nasolabial folds
- Cross-linked sodium hyaluronate at 23 mg/mL, of non-animal origin from Streptococcus equi bacteria
- Contains lidocaine hydrochloride 0.3%, which reduces pain and discomfort during injection
- Can be delivered by needle or by cannula, a 25G x 2 inch or 22G x 2 3/4 inch
- Cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres
- BDDE cross-linking agent present at 2 ppm or less
- Supplied with two 27G 1/2 inch needles, three patient record labels and an international implant card
- Manufactured by Croma-Pharma in Austria
Wskazania i zastosowanie profesjonalne
Główne wskazania
- Lip augmentation, to make the lips fuller
- Moderate to severe nasolabial folds, the deep lines running from the edge of the nose to the outer corners of the mouth
- For adults aged 18 or older; not to be used in people under the age of 18
Zastosowanie profesjonalne
Saypha Lips Lidocaine is intended for an appropriately trained healthcare professional who is qualified or accredited in accordance with national law, and is not intended to be used by lay persons. It is injected into the mid to deep dermis or submucosa, using the supplied 27G 1/2 inch needle or, where the practitioner prefers, a 25G x 2 inch or 22G x 2 3/4 inch cannula. For healthy adults the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session; where other forms of lidocaine are used concurrently, whether topical or injected, the maximum total dose must be considered. Patients should avoid strenuous exercise and exposure to extensive sun or heat in the first 48 hours after injection.
Obszary zabiegowe
- Lips, by submucosal injection
- Nasolabial folds, by mid to deep dermis injection
Profil pacjenta
For adults 18 years of age or older, assessed as suitable by the treating practitioner. It must not be used in those who tend to develop hypertrophic scars, have pigment disorders or a susceptibility to keloid formation, since treatment may trigger these complications. It must not be used in those known to be hypersensitive to hyaluronic acid, gram-positive bacterial proteins, lidocaine hydrochloride or amide-type local anaesthetics, since treatment may trigger allergic reactions of varying severity. It must not be used in pregnant or breast-feeding women, or in individuals younger than 18 years of age.
Jak działa Saypha Lips Lidocaine
Saypha Lips Lidocaine works through cross-linked hyaluronic acid at 23 mg/mL, placed in the lip submucosa or the mid to deep dermis where it adds volume. The gel is cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres, and the BDDE cross-linking agent is present at 2 ppm or less. The lidocaine hydrochloride at 0.3% is integrated into the implant in an ancillary role, to reduce pain and discomfort caused by the injection, which matters in the lip more than almost anywhere else. It does not change how the gel behaves in tissue.
Dlaczego warto zamawiać w Allpara
Allpara oferuje oryginalne, sprawdzone produkty SAYPHA od zweryfikowanych dostawców, z pełną identyfikowalnością partii i wsparciem ekspertów. Obsługujemy kliniki i specjalistów medycyny estetycznej, oferując produkty z certyfikatem CE, szybką dostawę na terenie całej UE z naszego magazynu w UE oraz konkurencyjne ceny hurtowe. Najważniejsze są dla nas bezpieczeństwo, satysfakcja i efekty Twoich pacjentów - z dedykowanym wsparciem posprzedażowym dla Twojego spokoju.
Najczęściej zadawane pytania
How does Saypha Lips Lidocaine differ from Saypha Filler Lidocaine?
Both carry 2.3% sodium hyaluronate with lidocaine 0.3% and share the same registered indication and placement, the mid to deep dermis or submucosa. Saypha Lips Lidocaine additionally documents a cannula option, a 25G x 2 inch or 22G x 2 3/4 inch cannula in place of the supplied needle.
Can Saypha Lips Lidocaine be injected with a cannula?
Yes. Two 27G 1/2 inch needles are supplied, and a 25G x 2 inch or 22G x 2 3/4 inch cannula may be affixed instead, following the same assembly steps.
Więcej od Croma-Pharma
POLYPHIL pozycji w ofercie ALLPARA do użytku profesjonalnego, kupowanych bezpośrednio i z certyfikatem przy każdej wysyłce.
POLYPHIL Produkty
Zobacz wszystkie 4Alternatywy dla kliniki
Wróć tam, gdzie skończyłeś
Saypha Lips Lidocaine
Saypha Lips Lidocaine is a viscoelastic implant from Croma-Pharma in Austria, designed for lip augmentation and moderate to severe nasolabial folds. Practitioners must inject it into the mid to deep dermis or submucosa, using the needle or an affixed 25G x 2 inch or 22G x 2 3/4 inch cannula. Its cross-linked hyaluronic acid from Streptococcus equi bacteria, phosphate buffered at pH 6.7 to 7.3, gives 2.3% sodium hyaluronate (23 mg/mL) and lidocaine HCl 0.3%. Each box holds one pre-filled 1.0 mL syringe with two 27G 1/2 inch needles, three patient record labels and an international implant card.
Najważniejsze zalety: Saypha Lips Lidocaine
- Indicated for lip augmentation and for correcting moderate to severe nasolabial folds
- Cross-linked sodium hyaluronate at 23 mg/mL, of non-animal origin from Streptococcus equi bacteria
- Contains lidocaine hydrochloride 0.3%, which reduces pain and discomfort during injection
- Can be delivered by needle or by cannula, a 25G x 2 inch or 22G x 2 3/4 inch
- Cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres
- BDDE cross-linking agent present at 2 ppm or less
- Supplied with two 27G 1/2 inch needles, three patient record labels and an international implant card
- Manufactured by Croma-Pharma in Austria
Wskazania i zastosowanie profesjonalne
Główne wskazania
- Lip augmentation, to make the lips fuller
- Moderate to severe nasolabial folds, the deep lines running from the edge of the nose to the outer corners of the mouth
- For adults aged 18 or older; not to be used in people under the age of 18
Zastosowanie profesjonalne
Saypha Lips Lidocaine is intended for an appropriately trained healthcare professional who is qualified or accredited in accordance with national law, and is not intended to be used by lay persons. It is injected into the mid to deep dermis or submucosa, using the supplied 27G 1/2 inch needle or, where the practitioner prefers, a 25G x 2 inch or 22G x 2 3/4 inch cannula. For healthy adults the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session; where other forms of lidocaine are used concurrently, whether topical or injected, the maximum total dose must be considered. Patients should avoid strenuous exercise and exposure to extensive sun or heat in the first 48 hours after injection.
Obszary zabiegowe
- Lips, by submucosal injection
- Nasolabial folds, by mid to deep dermis injection
Profil pacjenta
For adults 18 years of age or older, assessed as suitable by the treating practitioner. It must not be used in those who tend to develop hypertrophic scars, have pigment disorders or a susceptibility to keloid formation, since treatment may trigger these complications. It must not be used in those known to be hypersensitive to hyaluronic acid, gram-positive bacterial proteins, lidocaine hydrochloride or amide-type local anaesthetics, since treatment may trigger allergic reactions of varying severity. It must not be used in pregnant or breast-feeding women, or in individuals younger than 18 years of age.
Jak działa Saypha Lips Lidocaine
Saypha Lips Lidocaine works through cross-linked hyaluronic acid at 23 mg/mL, placed in the lip submucosa or the mid to deep dermis where it adds volume. The gel is cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres, and the BDDE cross-linking agent is present at 2 ppm or less. The lidocaine hydrochloride at 0.3% is integrated into the implant in an ancillary role, to reduce pain and discomfort caused by the injection, which matters in the lip more than almost anywhere else. It does not change how the gel behaves in tissue.
Dlaczego warto zamawiać w Allpara
Allpara oferuje oryginalne, sprawdzone produkty SAYPHA z pełną identyfikowalnością partii, produktami z certyfikatem CE, szybką dostawą na terenie całej UE i fachowym wsparciem posprzedażowym.
Najczęściej zadawane pytania
How does Saypha Lips Lidocaine differ from Saypha Filler Lidocaine?
Both carry 2.3% sodium hyaluronate with lidocaine 0.3% and share the same registered indication and placement, the mid to deep dermis or submucosa. Saypha Lips Lidocaine additionally documents a cannula option, a 25G x 2 inch or 22G x 2 3/4 inch cannula in place of the supplied needle.
Can Saypha Lips Lidocaine be injected with a cannula?
Yes. Two 27G 1/2 inch needles are supplied, and a 25G x 2 inch or 22G x 2 3/4 inch cannula may be affixed instead, following the same assembly steps.